Cell
Volume 184, Issue 25, 9 December 2021, Pages 6052-6066.e18
Journal home page for Cell

Article
The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses

https://doi.org/10.1016/j.cell.2021.11.010Get rights and content
Under a Creative Commons license
open access

Highlights

  • The C10 Fab’s orientation on E dimers allows bivalent IgG binding to each virion raft

  • C10 binding to DENV2 induces E dimer rearrangement by hitting a spring-loaded segment

  • Only E dimers with asymmetric environment on DENV2 virions can bind C10

  • Bivalent binding to two different E dimers expands C10 neutralization breadth

Summary

The human monoclonal antibody C10 exhibits extraordinary cross-reactivity, potently neutralizing Zika virus (ZIKV) and the four serotypes of dengue virus (DENV1–DENV4). Here we describe a comparative structure-function analysis of C10 bound to the envelope (E) protein dimers of the five viruses it neutralizes. We demonstrate that the C10 Fab has high affinity for ZIKV and DENV1 but not for DENV2, DENV3, and DENV4. We further show that the C10 interaction with the latter viruses requires an E protein conformational landscape that limits binding to only one of the three independent epitopes per virion. This limited affinity is nevertheless counterbalanced by the particle’s icosahedral organization, which allows two different dimers to be reached by both Fab arms of a C10 immunoglobulin. The epitopes’ geometric distribution thus confers C10 its exceptional neutralization breadth. Our results highlight the importance not only of paratope/epitope complementarity but also the topological distribution for epitope-focused vaccine design.

Keywords

Flaviviruses
Zika virus
Dengue virus
broadly neutralizing antibodies
vaccine design
cryo-EM
X-ray crystallography

Data and code availability

Coordinates, structure factor files and cryo-EM maps are deposited in the Protein Data bank and Electron Microscopy Data Bank with PDB: 7A3N, 7A3O, 7A3P, 7A3Q, 7A3R, 7A3S, 7A3T, 7A3U, 7CTH, and EMDB: 30465. Any additional information required to reanalyze the data reported in this work paper is available from the lead contact upon request.

Cited by (0)

11

Present address: Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA

12

Present address: Department of Therapeutics Discovery, Amgen Research, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, USA

13

Present address: Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel

14

These authors contributed equally

15

Lead contact